脓毒症实验室诊断及其研究进展

doi:10.3969/j.issn.1673-8640.2014.03.024

检验医学 ›› 2014, Vol. 29 ›› Issue (3): 297-300.DOI: 10.3969/j.issn.1673-8640.2014.03.024

脓毒症实验室诊断及其研究进展

陈洪卫，梁冬雨，侯彦强

上海市松江区中心医院检验科，上海 201600

收稿日期:2013-05-13 出版日期:2014-03-30 发布日期:2014-04-19
通讯作者: 侯彦强，联系电话:021-67720946。
作者简介:陈洪卫，男，1987年生，学士，技师，主要从事感染免疫、肿瘤免疫及实验室诊断研究。　
基金资助:
上海市科委基金资助项目(12ZR1428200)；上海市松江区科委基金资助项目(12SJGGYY13)

Laboratory diagnosis for sepsis and its research advance

CHEN Hongwei,LIANG Dongyu,HOU Yanqiang.

Central Hospital of Songjiang District,Shanghai 201600,China

Received:2013-05-13 Online:2014-03-30 Published:2014-04-19

摘要/Abstract

摘要：

脓毒症是一类因多种病原菌引起的机体全身性的过度炎症反应，临床症状与全身性炎症反应综合征(SIRS)相似，由于目前缺少理想的实验室诊断指标，尽管近年来诊断和治疗的技术不断进步，但脓毒症发生率和死亡率仍居高不下。本文就近几年临床应用较多、研究较热门的诊断标志物作一综述。

关键词: 脓毒症, 诊断, 标志物, 敏感性, 特异性

Abstract:

Sepsis,a common deadly systemic infection caused by a variety of pathogens,has some clinical symptoms similar to the systemic inflammatory response syndrome (SIRS). Currently,many parameters have been used for the clinical diagnosis of sepsis,however,none of them has gained unanimous acceptance as a specific parameter for sepsis. Despite of the development in diagnositic and therapeutic techniques,the incidence and mortality still remain high. This article summarizes widely applied or hot research parameter for the clinical diagnosis.

中图分类号:

R446.5

陈洪卫，梁冬雨，侯彦强. 脓毒症实验室诊断及其研究进展[J]. 检验医学, 2014, 29(3): 297-300.

CHEN Hongwei, LIANG Dongyu, HOU Yanqiang.. Laboratory diagnosis for sepsis and its research advance[J]. , 2014, 29(3): 297-300.

参考文献

[1] Gonsalves MD,Sakr Y. Early identification of sepsis[J]. Curr Infect Dis Rep,2010,12(5):329-335.
[2] Bauer M,Reinhart K. Molecular diagnostics of sepsis-where are we today[J]. Int J Med Microbiol,2010,300(6):411-413.
[3] Sankar V,Webster NR. Clinical application of sepsis biomarkers[J].J Anesth,2013,27(2):269-283.
[4] Waring WS,Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury[J]. Clin Toxicol (Phila),2011,49(8):720-728.
[5] Oncel MY,Dilmen U,Erdeve O,et al.Proad-renomedullin as a prognostic marker in neonatal sepsis[J]. Pediatr Res,2012,72(5):507-512.
[6] Pedersen T,Roikjaer O,Jess P. Increased levels of C-reactive protein and leukocyte count are poor predictors of anastomotic leakage following laparoscopic colorectal resection[J]. Dan Med J,2012,59(12):A4552.
[7] Vincent JL,Donadello K,Schmit X. Biomarkers in the critically ill patient: C-reactive protein[J].Cri Care Clin,2011,27(2):241-251.
[8] MclLwain RB,Timpa JG,Kurundkar AR,et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine[J]. Lab Invest,2010,90(1):128-139.
[9] Kibe S,Adams K,Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care[J].J Antimicrob Chemother,2011,66 (Suppl 2):ii33-ii40.
[10] Berg P,Lindhardt BØ.A procalcitonin-guided algorithm for pneumonia may reduce antibiotic use and treatment duration[J]. Ugeskr Laeger,2012,174(35):1986-1989.
[11] Bielinski SJ,Reiner AP,Nickerson D,et al.Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1)[J]. Atherosclerosis,2011,216(2):390-394.
[12] Kowalska I,Borawski J,Nikolajuk A,et al. Insulin sensitivity,plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy[J]. Endocrine,2011,40(1):95-101.
[13] Deneva-Koycheva TI,Vladimirova-Kitova LG,Angelova EA,et al.Serum levels of siCAM-1,sVCAM-1,sE-selectin,sP-selectin in healthy Bulgarian people[J].Folia Med,2011,53(2):22-28.
[14] Hoenigl M,Raggam RB,Wagner J,et al.Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome[J].Clin Biochem ,2013,46(3):225-229.
[15] Donadello K,Scolletta S,Covajes C,et al. suPAR as a prognostic biomarker in sepsis[J]. BMC Med,2012,10:2.
[16] Savva A,Raftogiannis M,Baziaka F,et al.Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis[J].J Infect,2011,63(5):344-350.
[17] Wagner J.Free DNA new potential analyte in clinical laboratory diagnostics[J].Biochem Med(Zagreb),2012,22(1):24-38.
[18] 侯彦强,梁冬雨,彭亮,等.分支链DNA Alu技术定量检测败血症患者血浆循环DNA的表达[J]. 检验医学,2012,27(12):1050-1053.
[19] Moreira VG,Prieto B,Rodriguez JS,et al.Usefulness of cell-free plasma DNA,procalcitonin and C-reactive protein as markers of infection in febrile patients[J]. Ann Clin Biochem,2010,47(Pt 3):253-258.
[20] Loens K,Bergs K,Ursi D,et al. Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens[J]. J Clin Microbiol,2007,45(2):421-425.
[21] Wu L,Li H,Jia CY,et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation[J].FEBS Lett,2012,586(7):1038-1043.

脓毒症实验室诊断及其研究进展

Laboratory diagnosis for sepsis and its research advance

RichHTML

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	彭伟, 李运改, 许静, 刘华, 杨翠霞, 沈云岳. 血清炎症因子联合PSA、f-PSA可辅助诊断前列腺癌[J]. 检验医学, 2023, 38(9): 849-854.
[2]	王慧英, 汤昱, 董利利, 王静. 肺炎支原体RNA检测用于肺炎患儿疾病诊断和疗效监测[J]. 检验医学, 2023, 38(9): 865-869.
[3]	孙信林, 叶星明, 李倩, 赵丽君. 支气管镜检查联合痰TB-RNA、血清TB-SA检测诊断菌阴肺结核[J]. 检验医学, 2023, 38(9): 870-873.
[4]	卫明珠, 潘继文, 罗锐, 陈俊辉. 凝血4项和肿瘤标志物对乙型肝炎相关肝癌的辅助诊断价值[J]. 检验医学, 2023, 38(9): 901-904.
[5]	梁栋, 梅月, 王腾蛟, 喻东. 基于cfDNA的NGS技术探究术后脓毒症患者血液微生物群特征[J]. 检验医学, 2023, 38(8): 753-759.
[6]	孙泽朋, 王洪彬, 王建东, 宋德伟, 肖鹏. 心肌损伤多肽和蛋白类标志物方法学分析和进展[J]. 检验医学, 2023, 38(8): 784-789.
[7]	潘信, 吕颖, 李阳, 李荣国. miR-24-3p靶向CHD5影响甲状腺癌细胞迁移能力、侵袭能力和放射敏感性[J]. 检验医学, 2023, 38(7): 640-646.
[8]	张欣, 马丽娟. 儿童心脏标志物检测的临床意义[J]. 检验医学, 2023, 38(6): 505-509.
[9]	韩雪, 闻柳, 宛杨. 唐氏筛查临界或高风险孕妇羊水染色体核型和基因组拷贝数变异结果分析[J]. 检验医学, 2023, 38(6): 548-552.
[10]	张楚, 王建红, 李瑞, 肖艳华, 王恒, 张品肖, 徐凝馨, 夏半半. 5 696例孕妇拓展性无创产前基因检测结果[J]. 检验医学, 2023, 38(6): 553-558.
[11]	张敏, 王彬宇, 迟伟群, 刘禹. 外泌体非编码RNA作为疾病诊断生物标志物的研究进展[J]. 检验医学, 2023, 38(6): 594-598.
[12]	高锋. 新型肿瘤标志物的临床应用——前景与挑战[J]. 检验医学, 2023, 38(4): 303-306.
[13]	张国良, 刘鷖雯, 何怡青, 许静, 杨翠霞, 高锋, 刘华. 血清HYAL1、HA在结直肠癌辅助诊断和疗效监测中的价值[J]. 检验医学, 2023, 38(4): 313-319.
[14]	袁爽, 冯磊, 郭小芬, 付小玲, 许静, 刘弘扬. 子宫内膜癌组织miR-433的表达及其与化疗敏感性的关系[J]. 检验医学, 2023, 38(4): 337-341.
[15]	肖秀美, 梁超, 刘彩红, 李晓光. 新型冠状病毒中和抗体与特异性抗体检测结果一致性分析[J]. 检验医学, 2023, 38(4): 352-356.